‘Patent Box’ Tax Probe to Be Dropped by EU, Boosting GSK, ARM

The European Union won’t pursue a probe into national programs that create tax breaks for research and development, giving a boost to pharmaceutical and technology companies that generate revenue from patented innovations.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.